Over time, we may see the cost going down, but right now these products are making a lot of money for these companies. Novo Nordisk ends Hims & Hers deal Novo Nordisk entered a partnership with Hims & Hers in April to make Wegovy more accessible to consumers, but ended the deal on Monday over claims the telehealth firm sold knockoff versions that put patient health at risk
Glucagon-like peptide 1 receptor (GLP-1 R) agonists This class of drugs (which includes liraglutide, exenatide, lixisenatide, and dulaglutide) acts on the pancreas, brain, and adipose tissue in a way similar to physiological GLP 1 and exerts its antidiabetic effect through controlling food intake, energy absorption, and glucose-dependent insulin secretion [69]
If it is because of prior authorization, reach out to your healthcare provider
As body weight reduces, so do calorie requirements
Should I consider an SGLT2 inhibitor instead of or in addition to a GLP-1 medication, especially if I have heart failure or kidney disease